-80.9%
CLSK vs THC
+1,633.5%
-1,714.5%
-98.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.8% | -0.3% | -2.5% | -2.7% |
| 7D | +8.0% | +1.0% | +7.0% | +7.8% |
| 30D | -27.9% | +5.3% | -33.2% | -29.2% |
| 3M | -42.3% | +7.1% | -49.4% | -43.8% |
| 6M | -50.0% | +46.0% | -96.0% | -56.0% |
| YTD | -34.3% | +43.9% | -78.2% | -42.5% |
| 1Y | -44.5% | +45.4% | -89.9% | -51.4% |
| 3Y | +74.5% | +421.3% | -346.7% | +3.9% |
| 5Y | -69.0% | +261.5% | -330.4% | -79.9% |
| All | -80.9% | +1,633.5% | -1,714.5% | -89.4% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling